87 related articles for article (PubMed ID: 954816)
1. Effects of chlorprothixene isomers on platelet 5-hydroxytryptamine receptors: evidence for different 5-hydroxytryptamine conformations at uptake and stimulatory sites.
Drummond AH; Whigham KA; Prentice CR
Eur J Pharmacol; 1976 Jun; 37(2):385-8. PubMed ID: 954816
[TBL] [Abstract][Full Text] [Related]
2. The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets.
Boullin DJ; Grimes RP; Orr MW
Br J Pharmacol; 1975 Dec; 55(4):555-7. PubMed ID: 2360
[TBL] [Abstract][Full Text] [Related]
3. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets.
Bevan J; Heptinstall S
Thromb Res; 1983 Jun; 30(5):415-23. PubMed ID: 6612677
[TBL] [Abstract][Full Text] [Related]
4. Human platelet 5HT receptors: characterisation and functional association.
Peters JR; Grahame-Smith DG
Eur J Pharmacol; 1980 Dec; 68(3):243-56. PubMed ID: 7202490
[TBL] [Abstract][Full Text] [Related]
5. Urapidil inhibits 5-hydroxytryptamine induced platelet aggregation and 14C-5-hydroxytryptamine uptake in platelets.
Storck J; Kirsten R
Curr Med Res Opin; 1990; 12(2):86-92. PubMed ID: 2390867
[TBL] [Abstract][Full Text] [Related]
6. Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets.
Drummond AH; MacIntyre DE; Olverman HJ
Br J Pharmacol; 1977 Apr; 59(4):661-2. PubMed ID: 858010
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral contraceptives on platelet noradrenaline and5-hydroxytryptamine receptors and aggregation.
Peters JR; Elliott JM; Grahame-Smith DG
Lancet; 1979 Nov; 2(8149):933-6. PubMed ID: 91026
[TBL] [Abstract][Full Text] [Related]
8. Interaction of lisuride with monoamine receptors on human blood platelets.
Glusa E; Markwardt F
Biochem Pharmacol; 1984 Feb; 33(3):493-6. PubMed ID: 6704167
[No Abstract] [Full Text] [Related]
9. Verapamil inhibition of 5-hydroxytryptamine (5HT) uptake in rat platelets.
Pietraszek MH; Buczko W
Eur J Pharmacol; 1987 Jun; 137(2-3):273-5. PubMed ID: 3609146
[TBL] [Abstract][Full Text] [Related]
10. Alpha-adrenoceptor-mediated actions of optical isomers and desoxy analogs of catecholimidazoline and norepinephrine in human platelets: in vitro.
Ahn CH; Hamada A; Miller DD; Feller DR
Biochem Pharmacol; 1986 Nov; 35(22):4095-102. PubMed ID: 3022751
[TBL] [Abstract][Full Text] [Related]
11. Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.
Boullin DJ; Glenton PA
Br J Pharmacol; 1978 Apr; 62(4):537-42. PubMed ID: 26445
[TBL] [Abstract][Full Text] [Related]
12. The 5-hydroxytryptamine system of blood platelets: physiology and pathophysiology.
Pletscher A
Int J Cardiol; 1987 Feb; 14(2):177-88. PubMed ID: 3818134
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of agonist-induced platelet aggregation, Ca2+ mobilization and granule secretion by guanosine 5'-[beta-thio]diphosphate and GDP in intact platelets. Evidence for an inhibitory mechanism unrelated to the inhibition of G-protein-GTP interaction.
Krishnamurthi S; Patel Y; Kakkar VV
Biochem J; 1988 Feb; 250(1):209-14. PubMed ID: 3355512
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
15. An assessment of platelet aggregation induced by 5-hydroxytryptamine.
Hilton BP; Cumings JN
J Clin Pathol; 1971 Apr; 24(3):250-8. PubMed ID: 5573439
[TBL] [Abstract][Full Text] [Related]
16. Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets.
Best LC; McGuire MB; Martin TJ; Preston FE; Russell RG
Biochim Biophys Acta; 1979 Mar; 583(3):344-51. PubMed ID: 221045
[No Abstract] [Full Text] [Related]
17. Increase of human platelet serotonin uptake by atypical histamine receptors.
Launay JM; Bondoux D; Oset-Gasque MJ; Emami S; Mutel V; Haimart M; Gespach C
Am J Physiol; 1994 Feb; 266(2 Pt 2):R526-36. PubMed ID: 8141412
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F
Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.
Huzoor-Akbar ; Mukhopadhyay A; Anderson KS; Navran SS; Romstedt K; Miller DD; Feller DR
Biochem Pharmacol; 1985 Mar; 34(5):641-7. PubMed ID: 3156599
[TBL] [Abstract][Full Text] [Related]
20. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
